Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/28434
Title: | Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimers's Disease Pathology | Authors: | Rosenberger, Andrea F.N. Hilhorst, Riet Coart, Elisabeth GARCIA BARRADO, Leandro Naji, Faris Rozemuller, Annemieke J.M. Van der Flier, Wiesje M. Scheltens, Philip Hoozemans, Jeroen J.M. Van der Vies, Saskia M. |
Issue Date: | 2016 | Source: | Journal of Alzheimer's disease, 49(4), p. 927-943 | Abstract: | Alzheimer’s disease (AD) is characterized by a long pre-clinical phase (20–30 years), during which significant brain pathology manifests itself. Disease mechanisms associated with pathological hallmarks remain elusive. Most processes associated with AD pathogenesis, such as inflammation, synaptic dysfunction, and hyper-phosphorylation of tau are dependent on protein kinase activity. The objective of this study was to determine the involvement of protein kinases in AD pathogenesis. Protein kinase activitywas determined in postmortem hippocampal brain tissue of 60 patients at various stages ofADand 40 nondemented controls (Braak stages 0-VI) using a peptide-based microarray platform. We observed an overall decrease of protein kinase activity that correlated with disease progression. The phosphorylation of 96.7% of the serine/threonine peptides and 37.5% of the tyrosine peptides on the microarray decreased significantly with increased Braak stage (p-value <0.01). Decreased activity was evident at pre-clinical stages of AD pathology (Braak I-II). Increased phosphorylation was not observed for any peptide. STRING analysis in combination with pathway analysis and identification of kinases responsible for peptide phosphorylation showed the interactions between well-known proteins in AD pathology, including the Ephrin-receptor A1 (EphA1), a risk gene for AD, and sarcoma tyrosine kinase (Src), which is involved in memory formation. Additionally, kinases that have not previously been associated with AD were identified, e.g., protein tyrosine kinase 6 (PTK6/BRK), feline sarcoma oncogene kinase (FES), and fyn-associated tyrosine kinase (FRK). The identified protein kinases are new biomarkers and potential drug targets for early (pre-clinical) intervention. | Keywords: | Alzheimer’s disease; peptide microarray analysis; phospho-peptides; postmortem changes; protein kinase activity; signaling pathways | Document URI: | http://hdl.handle.net/1942/28434 | ISSN: | 1387-2877 | e-ISSN: | 1875-8908 | DOI: | 10.3233/JAD-150429 | ISI #: | 000367522800004 | Rights: | 2016 – IOS Press and the authors. All rights reserved This article is published online with Open Access and distributed under the terms of the Creative Commons Attribution Non-Commercial License. | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
JAD150429.pdf | Published version | 833.55 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
13
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
24
checked on Sep 27, 2024
Page view(s)
68
checked on Sep 6, 2022
Download(s)
104
checked on Sep 6, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.